These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 9066679

  • 21. Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles.
    Duale N, Lindeman B, Komada M, Olsen AK, Andreassen A, Soderlund EJ, Brunborg G.
    Mol Cancer; 2007 Aug 21; 6():53. PubMed ID: 17711579
    [Abstract] [Full Text] [Related]

  • 22. Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications.
    Chu W, Pak BJ, Bani MR, Kapoor M, Lu SJ, Tamir A, Kerbel RS, Ben-David Y.
    Oncogene; 2000 Jan 20; 19(3):395-402. PubMed ID: 10656687
    [Abstract] [Full Text] [Related]

  • 23. Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells.
    Marverti G, Ligabue A, Paglietti G, Corona P, Piras S, Vitale G, Guerrieri D, Luciani R, Costi MP, Frassineti C, Moruzzi MS.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):17-26. PubMed ID: 19446547
    [Abstract] [Full Text] [Related]

  • 24. [Lung resistance protein analysis in testicular cancer].
    Mándoky L, Géczi L, Doleschall Z, Csuka O, Bodrogi I, Bak M.
    Magy Onkol; 2002 Aug 01; 46(4):339-45. PubMed ID: 12563357
    [Abstract] [Full Text] [Related]

  • 25. Heat-shock protein expression in cisplatin-sensitive and -resistant human tumor cells.
    Hettinga JV, Lemstra W, Meijer C, Los G, de Vries EG, Konings AW, Kampinga HH.
    Int J Cancer; 1996 Sep 17; 67(6):800-7. PubMed ID: 8824551
    [Abstract] [Full Text] [Related]

  • 26. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer.
    Yahata H, Kobayashi H, Kamura T, Amada S, Hirakawa T, Kohno K, Kuwano M, Nakano H.
    J Cancer Res Clin Oncol; 2002 Nov 17; 128(11):621-6. PubMed ID: 12458343
    [Abstract] [Full Text] [Related]

  • 27. BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma.
    Beale PJ, Rogers P, Boxall F, Sharp SY, Kelland LR.
    Br J Cancer; 2000 Jan 17; 82(2):436-40. PubMed ID: 10646901
    [Abstract] [Full Text] [Related]

  • 28. The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivo.
    Fujimori S, Abe Y, Nishi M, Hamamoto A, Inoue Y, Ohnishi Y, Nishime C, Matsumoto H, Yamazaki H, Kijima H, Ueyama Y, Inoue H, Nakamura M.
    Int J Oncol; 2004 Aug 17; 25(2):413-8. PubMed ID: 15254739
    [Abstract] [Full Text] [Related]

  • 29. Overexpression of thioredoxin does not confer resistance to cisplatin in transfected human ovarian and colon cancer cell lines.
    Yamada M, Tomida A, Yoshikawa H, Taketani Y, Tsuruo T.
    Cancer Chemother Pharmacol; 1997 Aug 17; 40(1):31-7. PubMed ID: 9137526
    [Abstract] [Full Text] [Related]

  • 30. Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer.
    Koster R, van Vugt MA, Timmer-Bosscha H, Gietema JA, de Jong S.
    Expert Rev Mol Med; 2013 Sep 30; 15():e12. PubMed ID: 24074238
    [Abstract] [Full Text] [Related]

  • 31. Role of metallothionein in cisplatin sensitivity of germ-cell tumours.
    Meijer C, Timmer A, De Vries EG, Groten JP, Knol A, Zwart N, Dam WA, Sleijfer DT, Mulder NH.
    Int J Cancer; 2000 Mar 15; 85(6):777-81. PubMed ID: 10709094
    [Abstract] [Full Text] [Related]

  • 32. Acute application of cisplatin affects methylation status in neuroblastoma cells.
    Tabata K, Sakai H, Nakajima R, Saya-Nishimura R, Motani K, Okano S, Shibata Y, Abiko Y, Suzuki T.
    Oncol Rep; 2011 Jun 15; 25(6):1655-60. PubMed ID: 21424131
    [Abstract] [Full Text] [Related]

  • 33. Genetic basis of drug sensitivity in human testis tumour cells.
    Wang X, Hafezparast M, Masters JR.
    Int J Cancer; 1996 Feb 08; 65(4):426-31. PubMed ID: 8621221
    [Abstract] [Full Text] [Related]

  • 34. Cisplatin-DNA damage recognition proteins in human tumour extracts.
    Bissett D, McLaughlin K, Kelland LR, Brown R.
    Br J Cancer; 1993 Apr 08; 67(4):742-8. PubMed ID: 8471431
    [Abstract] [Full Text] [Related]

  • 35. Absence of sperm-specific lactate dehydrogenase-x in patients with testis cancer.
    Vogelzang NJ, Lange PH, Goldberg E.
    Oncodev Biol Med; 1982 Apr 08; 3(4):269-72. PubMed ID: 6291005
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Exceptional sensitivity of testicular germ cell tumour cell lines to the new anti-cancer agent, temozolomide.
    Pera MF, Köberle B, Masters JR.
    Br J Cancer; 1995 May 08; 71(5):904-6. PubMed ID: 7734313
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.